To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
 
  •  

Osteoporosis drug 'doubles cancer risk'

London, Sep 03 (ANI): A new study has shown that people who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet).

Oral bisphosphonates are a type of drug used to treat osteoporosis and other bone diseases and are the most commonly recommended treatment for such conditions.

Researchers from the University of Oxford's Cancer Epidemiology Unit and the Medicines and Healthcare products Regulatory Agency analysed data from the UK General Practice Research Database, which has anonymised patient records for around six million people registered with a NHS GP.

They focused on men and women aged over 40 years - 2,954 with oesophageal cancer, 2,018 with stomach cancer and 10,641 with colorectal (bowel) cancer diagnosed between 1995 and 2005. Each case was compared with five controls matched for age, sex, general practice and observation period.

They found that people with 10 or more prescriptions, or with prescriptions over about five years, had nearly double the risk of oesophageal cancer compared with people with no bisphosphonate prescriptions.

The study has been published on bmj.com. (ANI)
 
Connect with

Stem cells may stop osteoporosis, promote bone growth

Washington, Mar 5 (ANI): A new study has shown that tweaking a certain group of multipotent stem cells-mesenchymal stem cells-with a hormone called interferon (IFN) in our bodies, might stop osteoporosis and promote bone growth.Scientists from the Research Institute of the McGill University Health Centre say that IFN holds great promise to repair bones affected by osteoporosis."We have identified a new pathway, centered on IFN gamma, that controls the bone remodelling process both in-vivo and in-vitro.More studies.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login